Evidence map›Paper›PMID 37935563›Full record

ArticleBMJ open ophthalmology2023

Risk factors associated with progression from papilloedema to optic atrophy: results from a cohort of 113 patients.

Ruben Attia, Ruben Fitoussi, Kevin Mairot, Sarah Demortiere, Jan-Patrick Stellman, Penelope Tilsley, Bertrand Audoin, Thierry David, Natacha Stolowy

Open access · goldAbstract read
In one paragraph

Article in BMJ open ophthalmology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. OCT-Based Retina Assessment Reflects Visual Impairment in Multiple Sclerosis.Investigative ophthalmology & visual science · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Ruben AttiaOphthalmology, Hospital Timone, Marseille, France rubat@hotmail.fr.ORCID 0000-0001-6882-7555
Ruben FitoussiOphthalmology, Hospital Timone, Marseille, France.
Kevin MairotOphthalmology, Hospital Timone, Marseille, France.
Sarah DemortiereNeurology, Hospital Timone, Marseille, France.
Jan-Patrick StellmanNeuroimaging service, CRMBM, Marseille, France.
Penelope TilsleyNeuroimaging service, CRMBM, Marseille, France.
Bertrand AudoinNeurology, Hospital Timone, Marseille, France.
Thierry DavidOphthalmology, Hospital Timone, Marseille, France.ORCID 0000-0002-7192-1523
Natacha StolowyOphthalmology, Hospital Timone, Marseille, France.
Assistance Publique Hôpitaux de Marseille · FRCentre de Recherche en Neurobiologie - Neurophysiologie de Marseille · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe aim of this study was to assess the risk factors for atrophic progression of patients with papilloedema secondary to intracranial hypertension, using optical coherence tomography parameters.

methodsA retrospective study was conducted at Marseille University Hospitals' Ophthalmology departments between December 2015 and December 2021. All patients with papilloedema resulting from elevated intracranial hypertension at the initial presentation were included. Ophthalmological evaluations included analysing retinal nerve fibre layer (RNFL), ganglion cell layer (GCL) and total peripapillary retinal thickness (RT).

resultsThe study included 222 eyes from 113 patients. The main aetiologies of intracranial hypertension were idiopathic intracranial hypertension (49/113), intracranial tumours (33/113) and cerebral venous thrombosis (15/113). The initial RNFL and RT showed significant correlations with optic atrophy. The mean RNFL was 199.63 µm in the 'no atrophy' group and 365.28 µm in the 'atrophy' group (p<0.001). Similarly, the mean RT was 483.72 µm in the 'non-atrophy' group and 796.69 µm in the 'atrophy' group (p<0.001). The presence of peripapillary haemorrhages showed a strong correlated with optic atrophy with an OR=19.12 (p<0.001). Impaired initial visual acuity was also associated with final optic atrophy with an OR=7.76 (p=0.020). Furthermore, impaired initial GCL was a major predictor of optic atrophy (OR=18.25 (p=0.021)).

conclusionOur study highlights the risk factors for optic atrophy in papilloedema, aiming to facilitate the early detection of patients at a high risk of vision loss and enable more aggressive medical or surgical management.

Indexed as

Optic AtrophyPapilledemaPseudotumor CerebriHumansNerve FibersRetinal Ganglion CellsRetrospective StudiesRisk FactorsVision DisordersVisual FieldsImagingOptic Nerve

Identifiers

PMID37935563
PMCPMC10632874
OpenAlexW4388452650

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.